Peptide Dosages

cropped-pdlogo-nr

Peptide
Dosages

Menu

CJC-1295 DAC (2 mg Vial) & Ipamorelin (5 mg Vial) Dosage Protocol

Contents

Quickstart Highlights

  • CJC-1295 DAC: 1–2 mg weekly (1× or split into 2× injections)
  • Ipamorelin: 200–300 μg/day (usually 1×–2× daily)
  • Reconstitute CJC-1295 DAC in 1 mL bacteriostatic water (2 mg/mL)
  • Reconstitute Ipamorelin in 2–3 mL bacteriostatic water (1.67–2.5 mg/mL)
  • Store reconstituted vials at 2–8 °C; use within 30 days
CJC-1295 DAC (2 mg Vial) & Ipamorelin (5 mg Vial)
📘 Important: Before viewing any protocol, please consult our Prep & Injection Guide for essential preparation and safety instructions.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

CJC-1295 DAC (2 mg Vial): Standard / Gradual Approach

Reconstitute with 1 mL of bacteriostatic water to achieve 2 mg/mL (20 μg/unit). Each full vial = 2 mg.

Week Weekly Dose Per Injection Units (mL) Frequency
Weeks 1–4 1 mg/week 1 mg ~50 units (0.5 mL) 1× weekly

To split, administer 0.5 mg (25 units) twice weekly for smoother IGF-1 levels.

Reconstitution Steps

  1. Clean stopper with alcohol swab.
  2. Draw 1.0 mL bacteriostatic water into a sterile syringe.
  3. Inject slowly down vial wall; swirl gently until clear.
  4. Label with date; store at 2–8 °C; use within 30 days.

CJC-1295 DAC (2 mg Vial): Advanced / Aggressive Approach

Reconstitute with 1 mL of bacteriostatic water (2 mg/mL).

Week Weekly Dose Per Injection Units (mL) Frequency
Weeks 1–4 2 mg/week 2 mg ~100 units (1 mL) 1× weekly

Alternatively, split into 1 mg (50 units) twice weekly.

  1. Clean stopper with alcohol swab.
  2. Draw 3.0 mL bacteriostatic water; inject slowly.
  3. Swirl gently until clear; label and refrigerate.
  4. Use within 30 days; do not freeze.

Ipamorelin (5 mg Vial): Advanced / Aggressive Approach

Reconstitute with 2 mL of bacteriostatic water for 2.5 mg/mL (25 μg/unit), improving small-dose accuracy.

 
Week Daily Dose Per Injection Units (mL) Frequency
Weeks 1–4 300 μg/day 300 μg ~12 units (0.12 mL) 1× daily

For multiple daily pulses, rotate sites and maintain ≥10 units/inj.

  1. Clean stopper with alcohol swab.
  2. Draw 2.0 mL bacteriostatic water; inject slowly.
  3. Swirl gently until dissolved; refrigerate 2–8 °C.
  4. Discard after 30 days or if cloudy.

Combining CJC-1295 DAC & Ipamorelin in a Stack

Administer both peptides on the same protocol day:

  • CJC-1295 DAC: 1–2 mg weekly (see approach tables)
  • Ipamorelin: 200–300 μg/day (1×–2× daily)
  • Use separate syringes and injection sites; do not mix in one vial
Note: This guide is for educational purposes only. Always consult a qualified professional.

Supplies Needed

  • Peptide Vials:
    • CJC-1295 DAC (2 mg Vial) – Product ID: 1043
    • Ipamorelin (5 mg Vial) – Product ID: 1042
  • Insulin Syringes: 30–100 unit (one per injection)
  • Bacteriostatic Water: 30 mL
  • Alcohol Swabs: 1 box
Peptide Vial
Insulin Syringes
Bacteriostatic Water
Alcohol Pads

Protocol Overview

  • Goal: Synergistic GH/IGF-1 elevation
  • CJC-1295 DAC: 1–2 mg/week (1× or split 2×)
  • Ipamorelin: 200–300 μg/day (1–2× daily)
  • Cycle Length: 4–6 weeks, assess then repeat
  • Reconstitution: CJC-1295 in 1 mL, Ipamorelin in 2–3 mL

Dosing Protocol

  • Method: Subcutaneous or IM, rotate sites
  • CJC-1295: Once weekly (Monday preferred)
  • Ipamorelin: Once or twice daily (e.g., AM & bedtime)
  • Timing: Separate syringes; can align with meals or sleep
  • Duration: 4–6 weeks per cycle

Storage Instructions

  • Lyophilized: Keep frozen until reconstitution
  • Reconstituted: Store 2–8 °C; label date; discard after 30 days
  • Protect from light; keep upright
  • Avoid freeze–thaw cycles

Important Notes

  • Use a new sterile syringe & needle for each injection.
  • Rotate injection sites between thighs, abdomen, and deltoids.
  • Monitor for side effects; consult a professional if needed.
  • Do not mix peptides in the same syringe.

How This Works

  • CJC-1295 DAC: Long-acting GHRH analog; sustains GH & IGF-1 rise for ~6–8 days
  • Ipamorelin: Short-acting GH secretagogue; induces pulsatile GH spikes (half-life ~2 h)
  • Combined use amplifies both baseline GH (via CJC) and pulses (via Ipam), maximizing IGF-1

Potential Benefits & Side Effects

  • May improve recovery, sleep quality, and body composition
  • Supports tissue repair, collagen synthesis, and lean mass gain
  • Common mild side effects: injection-site irritation, headache
  • Monitor IGF-1 and glucose; avoid use if active cancer exists

Injection Technique

Simple guidelines for safe daily injections.

  • Clean vial rubber stopper & injection site with alcohol swabs
  • Insert needle at a 45–90° angle into subcutaneous tissue
  • Inject slowly & rotate sites (abdomen, thigh, etc.)

Lifestyle Factors

Complementary strategies for best outcomes.

  • Maintain a protein-rich diet and stay hydrated
  • Engage in regular exercise; allow adequate rest
  • Manage stress and prioritize quality sleep

Important Note

This guide is for educational purposes only. Always consult a qualified healthcare provider before starting or modifying any therapy.

References


Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice
— Biochem Pharmacol (2018)
View Source

Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes
— BioMed Res Int (2021)
View Source

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome
— Front Pharmacol (2024)
View Source

Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice
— Sci Rep (2024)
View Source
Subcutaneous Injection Technique
— BioMed Res Int (2021)
View Source
Parenteral Administration: Intradermal, Subcutaneous, and Intramuscular Routes
— Lippincott Williams & Wilkins (2016)
View Source
Vaccine Administration: Best Practices for Subcutaneous Injections
— CDC (2022)
View Source
Peptide Stability: How Long Do Peptides Last?
— JPT Peptide Technologies Blog (2023)
View Source

Peptide Storage and Handling Guide: Stability of Reconstituted Peptides
— Creative Peptides Resource (2023)
View Source
Pure Lab Peptides
— 5-Amino-1MQ 10mg product page (quality and batch documentation)
View Source

References


  • Journal of Clinical Endocrinology & Metabolism
    — Prolonged stimulation of GH and IGF-I secretion by CJC-1295 in healthy adults
    View Source

  • European Journal of Endocrinology
    — Ipamorelin, the first selective growth hormone secretagogue
    View Source

  • Endocrine Reviews
    — Growth hormone secretagogues: mechanisms and clinical applications
    View Source

  • Sleep Medicine Reviews
    — Sleep and the GH/IGF-1 axis: physiological and clinical implications
    View Source

  • Bachem
    — Handling and storage guidelines for peptides (lyophilized stability)
    View Source

  • Bachem
    — Reconstituted peptide storage and stability recommendations
    View Source

  • Translational Andrology and Urology (PMC)
    — GH secretagogues in body composition management for hypogonadal males
    View Source

  • International Journal of Surgery (PubMed)
    — Ipamorelin for postoperative ileus: tolerability and safety in bowel resection patients
    View Source

  • NCBI Bookshelf
    — Parenteral medication administration: subcutaneous injection technique
    View Source

  • CDC
    — Vaccine administration guidelines: subcutaneous route (no aspiration required)
    View Source

  • Growth Hormone & IGF Research (ScienceDirect)
    — Ipamorelin induces longitudinal bone growth in rats
    View Source

  • Physiological Reviews
    — The somatotropic axis: GH and IGF-1 regulation and actions
    View Source

  • Clinical Drug Investigation (PMC)
    — Subcutaneous drug delivery: pharmacokinetic considerations
    View Source

  • Pure Lab Peptides
    — CJC-1295 DAC (2 mg) product page
    View Source

  • Pure Lab Peptides
    — Ipamorelin (5 mg) product page
    View Source